BioPharma
2024 May Have Regulations Change In The Biopharma Backdrop
The scenario is that the regulators are all ramping up pressure when it comes to the biopharma industry in 2024. Pharma companies not only happen to need to jump through new hoops when it comes to an increasingly intricate...
News
US, UK Regulatory Changes Lined Up In 2024 For Life Sciences
Prominent regulatory changes throughout the numerous medical fields are coming in 2024, with pharma and medical device companies urged to be on with a year of legal edits.
Right from the UK’s reworking of the Voluntary Scheme for Branded Medicines-...
News
Differences Between Clinical and Commercial Drug Manufacturing
In the pharmaceutical industry, the process of manufacturing drugs for clinical trials differs significantly from the process of manufacturing drugs for commercial distribution. While both require adherence to good manufacturing practices (GMP), clinical manufacturing presents unique challenges that must...
Drug Research
Critical Chronic Issues Adapt Well To Synthetic Antibiotics
Antimicrobial Resistance- AMR as it is referred to, is rising, and an AMR review that was commissioned by the UK Government has gone on to predict that by 2050, an additional 10 million people may as well succumb to...
News
2024 Global Pharma Outlook Looks Challenging For Pharma Cos.
Certain tectonic shifts in the healthcare market have gone on to push the pharma sector toward painful transformations in recent years. It is indeed quite evident that the traditional commercial model has gone one be upended permanently. In 2024,...
Drug Research
US Federal & State Drug Pricing Posing Major Challenges
The pharmaceutical sector has gone on to face pressure as well as uncertainty in 2023, and that is in all likelihood going to continue in 2024, partially due to the execution as well as evolution of the Inflation Reduction...
BioPharma
M&A Revival In The Biopharmaceutical Sector Back On Track
It is worth noting that the biopharmaceutical sector has gone on to experience a revival when it comes to mergers and acquisitions in the second half of 2023. One can see three major reasons resulting in this uptick in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read